Pfizer banks on King Pharma's new painkillers

By MATTHEW PERRONE 2010-10-12T18:10:55Z WASHINGTON (AP) -- Pfizer's purchase of King Pharmaceuticals announced Tuesday represents a $3.6 billion investment in an emerging class of painkillers that are designed to be less addictive than older pills such as OxyContin. The new products have been touted by federal health officials as an important way to curb prescription drug abuse, but they are relatively untested in the marketplace....

Read the whole article on AP Health

More from AP Health